⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28033016 | 0.98 | GLI1 (0.35) | — | |
| SCHEMBL325433 | 0.80 | — | — | |
| SCHEMBL15330716 | 0.80 | — | — | |
| SCHEMBL931733 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL1703549 | 0.78 | CYP2D6 (0.37) | — | |
| SCHEMBL15149517 | 0.77 | — | — | |
| Hydrochloric Acid SCHEMBL30530744 | 0.76 | — | — | |
| SCHEMBL3642481 | 0.74 | MAPT (0.34) | — | |
| SCHEMBL7218636 | 0.74 | USP2 (0.30) | — | |
| Hydrochloric Acid SCHEMBL8733450 | 0.72 | MAPT (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1146790-A4 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORP (US) | 2004-03-17 | — | — | EP | claimed |
| JP-2002535256-A | — | — | 2002-10-22 | — | — | JP | claimed |
| EP-1146790-A1 | COMPOUNDS AND METHODS | SmithKline Beecham Corporation (US) | 2001-10-24 | — | — | EP | claimed |
| WO-2000042852-A1 | COMPOUNDS AND METHODS | SMITHKLINE BEECHAM CORPORATION (US) | 2000-07-27 | — | — | WO | claimed |
| US-20250171414-A1 | COMPOUND SERVING AS MASP-2 INHIBITOR, PHARMACEUTICAL COMPOSITION, PREPARATION METHOD THEREFOR, AND USE THEREOF | WUHAN CREATERNA SCIENCE AND TECHNOLOGY CO., LTD. (CN) | 2025-05-29 | — | — | US | disclosed |
| EP-3864020-A1 | MACROCYCLIC FLU ENDONUCLEASE INHIBITORS | Janssen BioPharma, Inc. (US) | 2021-08-18 | — | — | EP | disclosed |
| CN-109715630-A | β -lactamase inhibitor compounds | 恩塔西斯治疗有限公司 | 2019-05-03 | — | — | CN | disclosed |
| CN-104364254-B | Heterobicyclic compounds as beta-lactamase inhibitors | 恩塔西斯治疗有限公司 | 2017-02-22 | — | — | CN | disclosed |
| EP-2844642-A1 | COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS | ARIAD PHARMACEUTICALS, INC. (US) | 2015-03-11 | — | — | EP | disclosed |
| EP-2834239-A1 | HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS | Astrazeneca AB (SE) | 2015-02-11 | — | — | EP | disclosed |
| WO-2013169401-A1 | COMPOUNDS FOR INHIBITING CELL PROLIFERATION IN EGFR-DRIVEN CANCERS | ARIAD PHARMACEUTICALS, INC. (US) | 2013-11-14 | — | — | WO | disclosed |
| WO-2013150296-A1 | HETEROBICYCLIC COMPOUNDS AS BETA-LACTAMASE INHIBITORS | ASTRAZENECA AB (SE) | 2013-10-10 | — | — | WO | disclosed |
| CN-101801953-A | Tetrahydropyridyl carboxamide derivatives as TRPV1 antagonists | ABBOTT LAB | 2010-08-11 | — | — | CN | disclosed |
| CN-101801953-A | Tetrahydropyridyl carboxamide derivatives as TRPV1 antagonists | ABBOTT LAB | 2010-08-11 | — | — | CN | disclosed |
| WO-2010007382-A1 | BENZAZEPINE DERIVATIVES AND THEIR USE AS HSTAMINE H3 ANTAGONISTS | TAKEDA PHARMACEUTICAL COMPANY LIMITED. (JP) | 2010-01-21 | — | — | WO | disclosed |
| EP-2091936-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | Purdue Pharma LP (US) | 2009-08-26 | — | — | EP | disclosed |
| WO-2008133973-A1 | THERAPEUTIC AGENTS USEFUL FOR TREATING PAIN | PURDUE PHARMA L.P. (DE) | 2008-11-06 | — | — | WO | disclosed |
| EP-1622911-A2 | PYRROLO[1,2-B]PYRIDAZINE COMPOUNDS AND THEIR USE AS CRF-1 RECEPTOR ANTAGONISTS | Pharmacia & Upjohn Company LLC (US) | 2006-02-08 | — | — | EP | disclosed |
| WO-2004099213-A2 | PYRROLO (1,2-B) PYRIDAZINE COMPOUNDS AND THEIR USE AS CRF-1 RECEPTOR ANTAGONISTS | PHARMACIA & UPJOHN COMPANY LLC (US) | 2004-11-18 | — | — | WO | disclosed |
| US-5525600-A | COMPOUND USEFUL AS ANTIPSYCHOTIC, ANTIDEPRESSANT AND ANXIBLYTIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1996-06-11 | — | — | US | disclosed |